Immunotherapies for neurodegenerative diseases: current status and potential of plant-made biopharmaceuticals.
作者： Jaime I Arevalo-Villalobos , Sergio Rosales-Mendoza , Sergio Zarazua
DOI: 10.1080/14760584.2016.1229602
关键词:
摘要: ABSTRACTIntroduction: Neurodegenerative diseases (NDs) have a serious impact on global health with no effective treatments available to date. Vaccination has been proposed as therapeutic approach for NDs, and clinical evaluations of some candidates Alzheimer’s disease multiple sclerosis are ongoing. Moreover, monoclonal antibodies passive immunotherapy under evaluation Alzheimer’s, synucleinopathies, sclerosis.Areas covered: With the consolidation plant-based systems production oral delivery biopharmaceuticals, interesting perspectives arise in fight against NDs. Based analysis current biomedical literature, role plant-made biopharmaceuticals outlook how this technology is leading new potential developments NDs presented review.Expert commentary: Substantial innovations following years expected consequence applying molecular pharming
sci-hub.se 参考文章(75)
Justyna Godyń, Jakub Jończyk, Dawid Panek, Barbara Malawska, Therapeutic strategies for Alzheimer's disease in clinical trials Pharmacological Reports. ,vol. 68, pp. 127- 138 ,(2016) , 10.1016/J.PHAREP.2015.07.006
PS Rommer, A Dudesek, O Stüve, UK Zettl, None, Monoclonal antibodies in treatment of multiple sclerosis Clinical and Experimental Immunology. ,vol. 175, pp. 373- 384 ,(2014) , 10.1111/CEI.12197
Cristina d’Abramo, Christopher M. Acker, Heidy Jimenez, Peter Davies, Passive Immunization in JNPL3 Transgenic Mice Using an Array of Phospho-Tau Specific Antibodies PLOS ONE. ,vol. 10, pp. e0135774- ,(2015) , 10.1371/JOURNAL.PONE.0135774
Martin F. Bachmann, Piers Whitehead, Active immunotherapy for chronic diseases. Vaccine. ,vol. 31, pp. 1777- 1784 ,(2013) , 10.1016/J.VACCINE.2013.02.001
Veronica Lindström, Therese Fagerqvist, Eva Nordström, Fredrik Eriksson, Anna Lord, Stina Tucker, Jessica Andersson, Malin Johannesson, Heinrich Schell, Philipp J. Kahle, Christer Möller, Pär Gellerfors, Joakim Bergström, Lars Lannfelt, Martin Ingelsson, Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice Neurobiology of Disease. ,vol. 69, pp. 134- 143 ,(2014) , 10.1016/J.NBD.2014.05.009
Celine A. Hayden, Maria E. Fischer, Bryan L. Andrews, Hayley C. Chilton, Debra D. Turner, John H. Walker, Ian R. Tizard, John A. Howard, Oral delivery of wafers made from HBsAg-expressing maize germ induces long-term immunological systemic and mucosal responses. Vaccine. ,vol. 33, pp. 2881- 2886 ,(2015) , 10.1016/J.VACCINE.2015.04.080
L. Lannfelt, N. R. Relkin, E. R. Siemers, Amyloid‐ß‐directed immunotherapy for Alzheimer's disease Journal of Internal Medicine. ,vol. 275, pp. 284- 295 ,(2014) , 10.1111/JOIM.12168
Therese Fagerqvist, Veronica Lindström, Eva Nordström, Anna Lord, Stina M. E. Tucker, Xingjian Su, Charlotte Sahlin, Alex Kasrayan, Jessica Andersson, Hedvig Welander, Thomas Näsström, Mats Holmquist, Heinrich Schell, Philipp J. Kahle, Hannu Kalimo, Christer Möller, Pär Gellerfors, Lars Lannfelt, Joakim Bergström, Martin Ingelsson, Monoclonal antibodies selective for α-synuclein oligomers/protofibrils recognize brain pathology in Lewy body disorders and α-synuclein transgenic mice with the disease-causing A30P mutation. Journal of Neurochemistry. ,vol. 126, pp. 131- 144 ,(2013) , 10.1111/JNC.12175
Sergio Rosales-Mendoza, Néstor Rubio-Infante, Sergio Zarazúa, Dania O Govea-Alonso, Guadalupe Martel-Gallegos, Leticia Moreno-Fierros, Plant-based vaccines for Alzheimer's disease: an overview. Expert Review of Vaccines. ,vol. 13, pp. 429- 441 ,(2014) , 10.1586/14760584.2014.874948
Andreas Loos, Herta Steinkellner, Plant glyco-biotechnology on the way to synthetic biology Frontiers in Plant Science. ,vol. 5, pp. 523- 523 ,(2014) , 10.3389/FPLS.2014.00523